Restricted
Restricted to 2nd line use after fluconazole.
FDA Treatment Indications: Therapy of suspected and confirmed invasive fungal infections such as candidemia, disseminated candidiasis, candida abscess & peritonitis infection.
Increases levels of sirolimus and nifedipine (mild).
Restricted to fungal infections that are known or suspected to be resistant to fluconazole or in patients intolerant to fluconazole.
Antimicrobial class: Echinocandin
Pregnancy category: C
Average serum half life: 15 hours
Urine penetration: Poor
Lung penetration: Therapeutic
CSF penetration: Poor
Biliary penetration: Therapeutic